These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8675956)

  • 21. [Pharmacology of fibrinolytics].
    Klöcking HP
    Z Gesamte Inn Med; 1979 Jan; 34(1):22-8. PubMed ID: 373275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of acylated streptokinase-plasminogen complex and streptokinase in healthy volunteers.
    Prowse CV; Hornsey V; Ruckley CV; Boulton FE
    Thromb Haemost; 1982 Apr; 47(2):132-5. PubMed ID: 7048621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shear Mode Bulk Acoustic Viscosity Sensor for Blood Coagulation Monitoring in Oral Anticoagulant Therapy.
    Song S; Chen D; Wang H; Guo Q; Yu W
    J Nanosci Nanotechnol; 2018 Dec; 18(12):8099-8104. PubMed ID: 30189925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
    Lussa A; Tymińska-Brzósko R
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979; 24():91-104. PubMed ID: 161647
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombin generation induced by the intrinsic or extrinsic coagulation pathway is accelerated by streptokinase, independently of plasminogen.
    Brommer EJ; Meijer P
    Thromb Haemost; 1993 Dec; 70(6):995-7. PubMed ID: 8165624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on fluidity of blood on the basis of fibrinolysis. 8. Analysis of fibrinolytic activity of the human blood activated with streptokinase and urokinase in vitro--with special reference to its similarity to fibrinolytic activity of fluid corpse blood.
    Ishizu H; Nobuhara M; Takata H
    Nihon Hoigaku Zasshi; 1971 Sep; 25(3):366-72. PubMed ID: 5167453
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro potentiation of urokinase-activated lysis of human fibrin clots.
    Singh K; Vézina C
    J Med; 1974; 5(6):297-302. PubMed ID: 4528600
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacology of thrombolytic drugs.
    Verstraete M; Collen D
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):33B-40B. PubMed ID: 3097100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring activity of fibrinolytic agents. A therapeutic challenge.
    Shafer KE; Santoro SA; Sobel BE; Jaffe AS
    Am J Med; 1984 May; 76(5):879-86. PubMed ID: 6232847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saruplase versus other fibrinolytic agents.
    Michels HR
    Int J Clin Pract Suppl; 1998 Nov; 99():21-2. PubMed ID: 10344037
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):566-81. PubMed ID: 138962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the reliability of plasminogen measurement employing the proactivator-activator converting method.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):551-65. PubMed ID: 138961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents.
    Dehmer GJ; Gresalfi N; Daly D; Oberhardt B; Tate DA
    J Am Coll Cardiol; 1995 Apr; 25(5):1069-75. PubMed ID: 7897118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On thrombolysis with various fibrinolytic agents. II. In vitro studies on intravitally-formed human blood clots].
    Schmidt HW
    Klin Wochenschr; 1966 Jun; 44(11):621-5. PubMed ID: 5987967
    [No Abstract]   [Full Text] [Related]  

  • 36. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 38. Different effect of 5,6-trans-prostaglandin E2 on plasminogen activation by urokinase and streptokinase.
    Urano T; Ikeda C; Shimokawa M; Kinoshita T
    Biochim Biophys Acta; 1994 Apr; 1205(2):258-61. PubMed ID: 8155706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of collagen on fibrinolysis.
    Engel AM; Alexander B
    Thromb Diath Haemorrh Suppl; 1973; 56():63-74. PubMed ID: 4376277
    [No Abstract]   [Full Text] [Related]  

  • 40. Beyond thrombolysis: other effects of thrombolytic drugs.
    Stringer KA
    Ann Pharmacother; 1994 Jun; 28(6):752-6. PubMed ID: 7919567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.